Ajanta Pharma Ltd - Company Profile
Powered by 
All the data and insights you need on Ajanta Pharma Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Ajanta Pharma Ltd Strategy Report
- Understand Ajanta Pharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Ajanta Pharma Clinical Trials
Determine Ajanta Pharma Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Ajanta Pharma Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Multicentric Randomized Double Blind Double Dummy Parallel Group Comparative Phase III Clinical Study to Evaluate the Efficacy Safety and Tolerability in subjects with Uncontrolled Essential Hypertension with stable Coronary Artery Disease (CAD) | GDCT0465664 | (metoprolol succinate ER + telmisartan + amlodipine besylate) | Cardiovascular | Coronary Artery Disease (CAD) (Ischemic Heart Disease); Idiopathic (Essential) Hypertension | Phase III | Planned | Ajanta Pharma Ltd |
| A Clinical, Phase III Study with the FDC of Metoprolol Succinate IP 47.50mg Eq. To Metoprolol Tartrate (as Extended Release) + Amlodipine Besilate IP Eq. To Amlodipine + Chlorthalidone IP (50mg + 5mg + 6.25mg & 50mg + 5mg + 12.5mg) Film Coated Bilayered Tablets | GDCT0465066 | (metoprolol succinate ER + amlodipine besylate + chlorthalidone) | Cardiovascular | Idiopathic (Essential) Hypertension | Phase III | Planned | Ajanta Pharma Ltd |
| A Multicentric Randomized Double Blind Double Dummy Parallel Group Two Arm Comparative Phase III Clinical Study to Evaluate Efficacy Safety and Tolerability of Loteprednol Etabonate Ophthalmic Suspension 1% W/v of Ajanta Pharma Ltd | GDCT0461697 | Loteprednol Etabonate | Immunology; Ophthalmology | Inflammation; Unspecified Ophthalmological Disorders | Phase III | Planned | Ajanta Pharma Ltd |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer